BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32836109)

  • 21. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
    Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G;
    JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of sleep problems on depressive disorders 1 year after developing acute coronary syndrome: The K-DEPACS study.
    Kim JM; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    J Affect Disord; 2017 Mar; 210():319-322. PubMed ID: 28073039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD).
    Hansen BH; Hanash JA; Rasmussen A; Hansen JF; Andersen NL; Nielsen OW; Birket-Smith M
    J Psychosom Res; 2012 Jan; 72(1):11-6. PubMed ID: 22200516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical correlates of insomnia in patients with acute coronary syndrome.
    Coryell VT; Ziegelstein RC; Hirt K; Quain A; Marine JE; Smith MT
    Int Heart J; 2013; 54(5):258-65. PubMed ID: 24097213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome.
    Kim SW; Kang HJ; Bae KY; Shin IS; Hong YJ; Ahn YK; Jeong MH; Berk M; Yoon JS; Kim JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):250-254. PubMed ID: 28689006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep duration, but not insomnia, predicts the 2-year course of depressive and anxiety disorders.
    van Mill JG; Vogelzangs N; van Someren EJ; Hoogendijk WJ; Penninx BW
    J Clin Psychiatry; 2014 Feb; 75(2):119-26. PubMed ID: 24345733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
    Colonna L; Andersen HF; Reines EH
    Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term cardiac outcomes of depression screening, diagnosis and treatment in patients with acute coronary syndrome: the DEPACS study.
    Kim JM; Stewart R; Kang HJ; Kim SY; Kim JW; Lee HJ; Lee JY; Kim SW; Shin IS; Kim MC; Shin HY; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    Psychol Med; 2021 Apr; 51(6):964-974. PubMed ID: 31907104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restless Legs Syndrome and Depression: Effect Mediation by Disturbed Sleep and Periodic Limb Movements.
    Koo BB; Blackwell T; Lee HB; Stone KL; Louis ED; Redline S;
    Am J Geriatr Psychiatry; 2016 Nov; 24(11):1105-1116. PubMed ID: 27526989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of depression at early and late phases following acute coronary syndrome on long-term cardiac outcomes.
    Kim JM; Stewart R; Kim JW; Kang HJ; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    J Affect Disord; 2020 Jan; 260():592-596. PubMed ID: 31541969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of new benzodiazepine prescriptions to older adults in primary care.
    Simon GE; Ludman EJ
    Gen Hosp Psychiatry; 2006; 28(5):374-8. PubMed ID: 16950371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual symptoms and recurrence during maintenance treatment of late-life depression.
    Dombrovski AY; Mulsant BH; Houck PR; Mazumdar S; Lenze EJ; Andreescu C; Cyranowski JM; Reynolds CF
    J Affect Disord; 2007 Nov; 103(1-3):77-82. PubMed ID: 17321595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insomnia and hypersomnia associated with depressive phenomenology and comorbidity in childhood depression.
    Liu X; Buysse DJ; Gentzler AL; Kiss E; Mayer L; Kapornai K; Vetró A; Kovacs M
    Sleep; 2007 Jan; 30(1):83-90. PubMed ID: 17310868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.
    Quante A; Regen F; Schindler F; Volkmer K; Severus E; Urbanek C; Luborzewski A; Roepke S; Anghelescu I
    Psychiatr Danub; 2013 Sep; 25(3):214-20. PubMed ID: 24048387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of homocysteine for depression after acute coronary syndrome.
    Kang HJ; Stewart R; Bae KY; Kim SW; Shin IS; Kang H; Moon WJ; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    Oncotarget; 2016 Oct; 7(42):69032-69040. PubMed ID: 27626182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
    Maras A; Schroder CM; Malow BA; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
    [No Abstract]   [Full Text] [Related]  

  • 37. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES; Howard C; Khan DA; Carmody TJ
    Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of depression in patients with acute coronary syndrome (DECARD) randomized trial: effects on and by self-reported health.
    Hjorthøj CR; Hansen BH; Hanash JA; Rasmussen A; Birket-Smith M
    Early Interv Psychiatry; 2015 Oct; 9(5):370-7. PubMed ID: 24576016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep disturbance after acute coronary syndrome: A longitudinal study over 12 months.
    von Känel R; Meister-Langraf RE; Zuccarella-Hackl C; Schiebler SLF; Znoj H; Pazhenkottil AP; Schmid JP; Barth J; Schnyder U; Princip M
    PLoS One; 2022; 17(6):e0269545. PubMed ID: 35657924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.